Experimental pill aims to protect kidneys from diabetes damage
NCT ID NCT06600412
Summary
This study is testing whether a new oral drug called R3R01 can help protect the kidneys in adults with type 2 diabetes. Researchers want to see if taking the drug for 3 months reduces the amount of protein leaking into the urine, which is a sign of kidney damage. The study will involve 60 participants, where 40 will receive R3R01 and 20 will receive a placebo pill for comparison.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Steno Diabetes Center Copenhagen
RECRUITINGCopenhagen, Copenhagen, 2730, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.